U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 050805
Company: GALDERMA LABS LP
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ORACEA DOXYCYCLINE 40MG CAPSULE;ORAL Prescription AB Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/26/2006 ORIG-1 Approval Type 3 - New Dosage Form STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050805lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/050805s000LTR.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/050805s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/15/2021 SUPPL-11 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050805s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/050805Orig1s011ltr.pdf
09/03/2015 SUPPL-10 Manufacturing (CMC)

Label is not available on this site.

06/24/2015 SUPPL-9 Manufacturing (CMC)

Label is not available on this site.

07/25/2013 SUPPL-8 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050805s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/050805Orig1s008ltr.pdf
11/07/2012 SUPPL-7 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050805s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/050805Orig1s007ltr.pdf
05/13/2010 SUPPL-2 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050805s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/050805s002ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
12/15/2021 SUPPL-11 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050805s011lbl.pdf
07/25/2013 SUPPL-8 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050805s008lbl.pdf
11/07/2012 SUPPL-7 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050805s007lbl.pdf
05/13/2010 SUPPL-2 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050805s002lbl.pdf
05/26/2006 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050805lbl.pdf

ORACEA

CAPSULE;ORAL; 40MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DOXYCYCLINE DOXYCYCLINE 40MG CAPSULE;ORAL Prescription No AB 217674 ALEMBIC
DOXYCYCLINE DOXYCYCLINE 40MG CAPSULE;ORAL Prescription No AB 217170 APOTEX
DOXYCYCLINE DOXYCYCLINE 40MG CAPSULE;ORAL Prescription No AB 218034 DR REDDYS
DOXYCYCLINE DOXYCYCLINE 40MG CAPSULE;ORAL Prescription No AB 216631 LUPIN
ORACEA DOXYCYCLINE 40MG CAPSULE;ORAL Prescription Yes AB 050805 GALDERMA LABS LP
Back to Top